Yazen AB prepares for growth and international expansion. The A round was led by Evli Growth Partners (Finland) and Helsana Healthlnvest (Switzerland). German Almaz Captial and Yabeo also participated, along with Aggregate Media and existing investor Luminar Ventures.

Yazen offers treatment for obesity through a combination of methods. In addition to medicines, patients also have the support of a team of experts as well as a weight loss app.

Moll Wendén’s team included David Klose (responsible partner) and Alexandra Johansson.

More information about the investment and Yazen AB can be found in their press release.